Invicro & icometrix to offer comprehensive imaging core lab services
Category: #health  By Pankaj Singh  Date: 2019-03-05
  • share
  • Twitter
  • Facebook
  • LinkedIn

Invicro & icometrix to offer comprehensive imaging core lab services

A Konica Minolta company Invicro LLC has reportedly entered into a partnership with icometrix to seamlessly offer the most comprehensive range of imaging core lab services in the world along with the most robust FDA approved MRI informatics capabilities via automated workflows.

As per trusted sources, pharmaceutical sponsors will encounter only one point of contact for study site set-up and training which will align with a single platform for managing data, sharing and analytics.

For the uninitiated, Invicro is a renowned supplier of quantitative imaging biomarkers, fundamental lab services, and software solutions for research and drug development. Meanwhile, Belgium-based icometrix is world’s leading software solutions provider with expertise in acquiring clinically meaningful information from brain MRI and CT scans, reported sources.

This unique collaboration brings together aligned core lab procedures and advanced imaging technologies with software for clinical trials that are FDA approved. The collaboration will aid the supply of a more effective and flexible solution to escalate drug discovery and development and offer better understandings in disease diagnostics.

Dr. Jacob Hesterman, Invicro’s Founding Partner and Head of R&D stated that the company is thrilled about the partnership with icometrix to mutually provide global imaging core lab services and cutting-edge analytics capabilities generating workflows with high-reliability and consistent data outcomes.
Hesterman further stated that Invicro’s Biotech and Pharma sponsors will profit from the combination of recognized core lab operational excellence and analytics with strong and trailblazing analysis tools for disease areas like Alzheimer’s, Multiple Sclerosis, and Traumatic Brain Injury, allowing statistically powerful quantitation as well as swift and accurate decision making.

For the record, the Boston-based Invicro was founded in 2008 with a mission of enhancing the function and role of imaging in translational medicine discovery and development in all therapeutic areas. As a part of Konica Minolta precision medicine organization and with its subsidiary Ambry Genetics, the company developed and leverages the latest tactics in quantitative biomarkers including genomics, quantitative pathology, and imaging, reported sources.  



About Author

Pankaj Singh

Email: [email protected]   

Pankaj Singh

Pankaj Singh Develops content for Market Size Forecasters, Algosonline, and a couple of other platforms. A Post Graduate in Management by qualification, he worked as an underwriter in the UK insurance domain before deciding to switch his field of profession. With exp...

Read More

More News By Pankaj Singh

Zelegent expands to OSA therapeutics with MISH platform acquisition
Zelegent expands to OSA therapeutics with MISH platform acquisition
By Pankaj Singh

  • MISH Technology stands for Minimally Invasive Suspension of the Hyoid and is a novel pre-clinical product line meant to treat obstructive sleep apnea (OSA).
  • SunGen Pharma and Elite Pharmaceuticals file an ANDA with the FDA
    SunGen Pharma and Elite Pharmaceuticals file an ANDA with the FDA
    By Pankaj Singh

    This is the second ANDA filed by both the companies, giving Elite Pharmaceutical the exclusive right to retail the drug.

    Elite Pharmaceuticals, Inc. a pharmaceutica...

Ribon Therapeutics doses first patient in RBN-2397 Phase 1 trial
Ribon Therapeutics doses first patient in RBN-2397 Phase 1 trial
By Pankaj Singh

  • The Phase 1 clinical trial assessing RBN-2397 will be the first clinical evaluation of monoPARP Inhibitor.
     
  • RBN-2397 is the company&rs...